U.S. COMPANY FILING
PFIZER INC — Form 10-Q filed 2026-08-04
Filing text preview
Pfizer's Q2 2026 revenue rose 2.6% to $15.03B, but net loss was $248M due to $4.325B asset impairments partially offset by $1.87B gain from ViiV sale. H1 revenue was $29.48B with net income of $2.44B. The company continues cost realignment and completed several transactions.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record